Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy.
Pharmaceuticals (Basel)
; 15(7)2022 Jul 16.
Article
in En
| MEDLINE
| ID: mdl-35890175
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Pharmaceuticals (Basel)
Year:
2022
Type:
Article
Affiliation country:
China